Ratings by Leerink Partners (Geoffrey Porges)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/2/2026 | Arcus Biosciences | RCUS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/15/2022 | Axcella Health Inc. | AXLA | Downgrade | Market Perform (Outperform) |
0.89 (4.58) |
414.61% | Details | |
| 8/2/2022 | Axcella Health Inc. | AXLA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2021 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/26/2021 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/21/2021 | Radius Health | RDUS | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/16/2021 | Theravance Biopharma | TBPH | Maintain | Outperform (N/A) |
|
Details | ||
| 7/20/2021 | Vertex | VRTX | Downgrade | Underperform (Market Perform) |
199.24 (456.69) |
129.22% | Details | |
| 6/3/2021 | MorphoSys AG | MOR | Upgrade | Outperform (Market Perform) |
19.20 (18.96) |
-1.25% | Details | |
| 5/17/2021 | Halozyme Therapeutics | HALO | New Coverage | Outperform (N/A) |
43.03 (67.37) |
56.57% | Details | |
| 3/30/2021 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/23/2021 | Translate Bio | TBIO | Downgrade | Market Perform (Outperform) |
16.37 (3.23) |
-80.27% | Details | |
| 3/23/2021 | Assembly Biosciences | ASMB | Downgrade | Market Perform (Outperform) |
4.69 (28.27) |
502.77% | Details | |
| 3/23/2021 | Acceleron Pharma | XLRN | Downgrade | Market Perform (Outperform) |
143.64 (178.75) |
24.44% | Details | |
| 3/23/2021 | Alexion Pharmaceuticals | ALXN | Downgrade | Market Perform (Outperform) |
155.25 (182.01) |
17.24% | Details | |
| 2/26/2021 | Pandion Therapeutics | PAND | Downgrade | Market Perform (Outperform) |
25.63 (60.05) |
134.3% | Details | |
| 1/26/2021 | Arcus Biosciences | RCUS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2020 | Amgen | AMGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/14/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/31/2020 | Radius Health | RDUS | New Coverage | Market Perform (N/A) |
12.02 (30.00) |
149.58% | Details | |
| 8/18/2020 | Principia Biopharma | PRNB | Downgrade | Market Perform (Outperform) |
99.25 (100.05) |
0.81% | Details | |
| 8/11/2020 | Pandion Therapeutics | PAND | New Coverage | Outperform (N/A) |
18.78 (60.05) |
219.76% | Details | |
| 8/11/2020 | Arcus Biosciences | RCUS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2020 | Principia Biopharma | PRNB | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2020 | Vertex | VRTX | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/31/2020 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2020 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/24/2020 | Radius Health | RDUS | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/8/2020 | Assembly Biosciences | ASMB | New Coverage | Outperform (N/A) |
23.91 (28.27) |
18.24% | Details | |
| 7/8/2020 | Radius Health | RDUS | New Coverage | Market Perform (N/A) |
14.06 (12.02) |
-14.51% | Details | |
| 6/16/2020 | Pfizer | PFE | New Coverage | Market Perform (N/A) |
33.36 (27.05) |
-18.91% | Details | |
| 6/3/2020 | Gilead Sciences | GILD | Upgrade | Outperform (Market Perform) |
73.26 (143.93) |
96.46% | Details | |
| 5/18/2020 | Axcella Health Inc. | AXLA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/15/2020 | Principia Biopharma | PRNB | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2020 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 5/4/2020 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/30/2020 | Gilead Sciences | GILD | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 3/26/2020 | Axcella Health Inc. | AXLA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2020 | FibroGen | FGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2020 | Gilead Sciences | GILD | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/31/2020 | Vertex | VRTX | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/28/2020 | Acceleron Pharma | XLRN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/1/2019 | Celgene | CELG | Maintain | Market Perform (N/A) |
|
Details | ||
| 10/30/2019 | Amgen | AMGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 10/23/2019 | Biogen | BIIB | Upgrade | Outperform (Market Perform) |
281.87 (272.73) |
-3.24% | Details | |
| 9/30/2019 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/5/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/3/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/28/2019 | Amgen | AMGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/15/2019 | resTORbio Inc. | TORC | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2019 | Radius Health | RDUS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2019 | Assembly Biosciences | ASMB | Maintain | Outperform (N/A) |
|
Details | ||
| 6/26/2019 | Abbvie | ABBV | Upgrade | Outperform (Market Perform) |
65.70 (230.11) |
250.24% | Details | |
| 6/3/2019 | Axcella Health Inc. | AXLA | New Coverage | Outperform (N/A) |
14.20 (4.58) |
-67.75% | Details | |
| 5/21/2019 | Gilead Sciences | GILD | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/21/2019 | Principia Biopharma | PRNB | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2019 | Assembly Biosciences | ASMB | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2019 | Amgen | AMGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/30/2019 | Biogen | BIIB | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/3/2019 | Celgene | CELG | Downgrade | Market Perform (Outperform) |
66.64 (108.24) |
62.42% | Details | |
| 11/19/2018 | Assembly Biosciences | ASMB | New Coverage | Outperform (N/A) |
24.39 (23.91) |
-1.97% | Details | |
| 11/13/2018 | resTORbio Inc. | TORC | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2018 | Theravance Biopharma | TBPH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2018 | FibroGen | FGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/26/2018 | Celgene | CELG | Maintain | Market Perform (N/A) |
|
Details | ||
| 10/24/2018 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/9/2018 | Principia Biopharma | PRNB | New Coverage | Outperform (N/A) |
26.37 (100.05) |
279.41% | Details | |
| 10/5/2018 | Zogenix, Inc. | ZGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/28/2018 | Dova Pharmaceuticals Inc | DOVA | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/17/2018 | Amgen | AMGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/11/2018 | FibroGen | FGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/4/2018 | Dova Pharmaceuticals Inc | DOVA | Maintain | Market Perform (N/A) |
|
Details |
